Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

PBMs Becoming More Open To Online Pharmacy Participation, Execs Say

  • News

Executive Summary

Pharmacy benefit management companies' reluctance to allow Internet pharmacies into their prescription provider networks is changing, online pharmacy executives said at a Global Business Research online pharmacy conference in San Francisco Sept. 23.

You may also be interested in...



Merck-Medco/CVS.com Deal Includes Specialty Drugs Mail-Order Agreement

CVS' ProCare subsidiary will become Merck-Medco's exclusive provider of specialty pharmaceutical mail-order services through an agreement that also gives Merck's pharmacy benefit management subsidiary up to a 10% stake in ProCare.

Merck-Medco/CVS.com Deal Includes Specialty Drugs Mail-Order Agreement

CVS' ProCare subsidiary will become Merck-Medco's exclusive provider of specialty pharmaceutical mail-order services through an agreement that also gives Merck's pharmacy benefit management subsidiary up to a 10% stake in ProCare.

FDA Role In Non-U.S. Drug Sites To Be Issue At Next Online Pharmacy Hearing

Future House hearings on Internet pharmacy sites will likely focus on international sites and federal agencies' roles in controlling them.

Table

View full table

Tags:
Latest Headlines

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds

Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing

Global Pharma Guidance Tracker – March 2024

See All
UsernamePublicRestriction

Register

PS034930

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By